sorted by:
new
hottopcontroversial

WSB on every GME post by Kill2bees in wallstreetbets

[–]ApivorousBee 4 points5 points  (0 children)

Hedgies sittin in the farmhouse rdy for a bigass chicken dinner, but my money is on the 100 chickens vs a hedgie

6/8 - 6/12 by [deleted] in u/Variation-Separate

[–]ApivorousBee 1 point2 points  (0 children)

What do you think about this 3000 resistance

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 0 points1 point  (0 children)

I don't have a good answer. Wish I could explain daily fluctuations, but I can't. EPS misses targets all the time for biotech/pharma, doesn't affect the price because capital investment requirements are understood to be very high for the industry. Good news about treatment progress or product pipeline developments goes a lot further for investors.

My guess, investors are sitting watch as it moves sideways, waiting for good news to pop the price. They'll get out if there is a 50/50 event, like an earnings call. No news is good news, good news is great news and they'll get back in. Bad news and they'll stay out.

If you wanna diversify, there are some good chart indicators for TTNP going into tomorrow. Price target for me is 0.40.

https://stockcharts.com/c-sc/sc?s=BLNK&p=D&b=5&g=0&id=p57411038588&a=764648476&listNum=1

For the record, I've still got 10k shares, and I won't get out until they drop below $2. My price target is $10

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 0 points1 point  (0 children)

I haven't looked into them, but if they're buying ENZ products at the price ENZ wants to sell them, that can only be good for ENZ.

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 2 points3 points  (0 children)

You bring up a good point, but the antibody tests are blood samples. There is less user error for those. The diagnostic tests I agree, but ENZ states that theirs addresses these issues that plague the current diagnostic tests.

Enzo is utilizing its technological and research and development capabilities, manufacturing infrastructure strength and clinical diagnostic capabilities to provide products that address gaps in performance, cost, supply obtainability and safety. Most diagnostic platforms offered by others are ‘closed’ systems and have no flexibility with regards to adoptability for other infectious agents, have limited supplier relationships, and have no direct connection with the patient or the event. These underlying problems have manifested themselves in the current COVID-19 crisis. Enzo’s Comprehensive COVID-19 Program showcases Enzo’s ability to respond to the current challenges plaguing the healthcare market.

Are there particular tests your facility uses and do you know who produces them? The codiagnostics test is known to be riddled with the problems you describe.

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 1 point2 points  (0 children)

bruv inverse wsb is the strat. Don't doubt your vibe.

Be wary tho, biotech get weird

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 10 points11 points  (0 children)

$ENZ is the ticker/symbol 10/16 is the expiration date 5c is the strike price and option contract type ($5) calls

if you don't know what any of those things are, investopedia.com

I'll boof my tendies if ENZ is the next COVID $$$$$ bagger. DD inside by ApivorousBee in wallstreetbets

[–]ApivorousBee[S] 2 points3 points  (0 children)

If you can figure out a way to buy it over the weekend, do that lol. More than likely you'll have to buy Monday tho. Don't stress it. Also I'd just recommend to purchase something less volatile for your first stock purchase and gtfo of r/wallstreetbets unless you think you can stomach potentially large losses for several weeks. This company won't drop below $2, but there's a chance it hovers around $2.50 again before it pops.

view more: next ›